¹é¼±ÇÏ ¸íÀÇ

ÆÄŲ½¼º´ ¼ö¼ú¹ý ¹è¿ì·Á °¢±¹ ÀÇ»çµéÀÌ Ã£´Â

¹é¼±ÇÏ ¸íÀÇ

  • ¼Ò ¼Ó
    ¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú
  • Àü¹®ºÐ¾ß
    ³úÁ¾¾ç, ÆÄŲ½¼, ÁøÁ¤Áõ/¾È¸é°æ·Ã, ÀÌ»ó¿îµ¿, °¨¸¶³ªÀÌÇÁ, ³ú½ÉºÎÀÚ±Ø ¼ö¼ú, ÃÊÀ½ÆÄ ÁýÀû Ä¡·á ¼ö¼ú

ÁÖ¿ä Áø·á ºÐ¾ß´Â ³úÁ¾¾ç, ³úÇϼöüÁ¾¾ç, ÆÄŲ½¼º´ÀÌ´Ù. 2004³â ³ú½ÉºÎÀڱؼúÀÌ º¸Çè¿¡ µîÀçµÅ ÆÄŲ½¼ ȯÀÚ¸¦ Æ÷ÇÔÇÑ ÀÌ»ó¿îµ¿Áúȯ ȯÀÚµéÀÌ º»°ÝÀûÀ¸·Î ³ú½ÉºÎÀڱؼúÀ» ½ÃÇà¹Þ±â ½ÃÀÛÇÒ ¹«·Æ 24½Ã°£ ¸ð´ÏÅ͸µ unitÀ» °®Ãá ¼¼°èÀû ¼öÁØÀÇ ÆÄŲ½¼ ¼¾Å͸¦ °³¼ÒÇØ ȯÀÚµéÀÇ ÀüÀÎÀû °ü¸®¸¦ ½ÃÇàÇϰí ÀÖ´Ù.
¾Æ½Ã¾Æ ÃÖÃÊ·Î ¾Æ½Ã¾Æ °¢±¹¿¡¼­ ¸ðÀÎ ÀÇ»çµé¿¡°Ô ³ú½ÉºÎÀڱؼú ¶óÀÌºê ¼ö¼ú ±³À°À» Çϱ⵵ Çß´Ù. ³ú½ÉºÎÀڱؼúÀº ³ú¿¡ Àü±ØÀ» ³ÖÀº ÈÄ Àü±ØÀÚ±ØÀ» Áà ºñÁ¤»óÀûÀ¸·Î Ȱ¼ºÈ­µÈ ÆÄŲ½¼º´ ȯÀÚÀÇ ½Å°æ¼¼Æ÷¸¦ ¾ïÁ¦ÇÏ´Â ¼ö¼úÀÌ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¼­¿ï´ëÇб³ Àǰú´ëÇÐ, ¹Ú»ç
  • ¼­¿ï´ëÇб³ Àǰú´ëÇÐ, ¼®»ç
  • ¼­¿ï´ëÇб³ Àǰú´ëÇÐ, Çлç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) ¼­¿ï´ëÇб³ ½Å°æ¿Ü°ú ±³¼ö
  • Åä¸Ó½º-Á¦ÆÛ½¼ ´ëÇб³ ±³È¯±³¼ö (2003 ~ 2004)
  • ÄÚ³Ú´ëÇб³ ±³È¯±³¼ö (2002 ~ 2003)

¼ö»ó³»¿ª

Awards List
  • 2006³â ´ëÇѽŰæ¿Ü°úÇÐȸ ½Éº¸¼º Çмú»ó

ÇÐȸȰµ¿

Academic activities
  • The Congress of Neurological Surgeons Á¤È¸¿ø
  • The Korean Neurosurgical Society Á¤È¸¿ø
  • The Korean Brain Tumor Society Á¤È¸¿ø
  • The Korean Skull Base Society Á¤È¸¿ø
  • The Korean Society of Stereotactic and Functional Neurosurgery Á¤È¸¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma
¹ßÇ¥³âµµ 2020.04.01 ¹ßÇ¥Áö Nat Genet
Á¦ ¸ñ STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
¹ßÇ¥³âµµ 2020.03.15 ¹ßÇ¥Áö Cells
Á¦ ¸ñ Determination of Parkinson Disease Laterality After Deep Brain Stimulation Using 123I FP-CIT SPECT
¹ßÇ¥³âµµ 2020.02.27 ¹ßÇ¥Áö Clin Nucl Med
Á¦ ¸ñ Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial
¹ßÇ¥³âµµ 2020.02.04 ¹ßÇ¥Áö J Neurooncol.
Á¦ ¸ñ Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease
¹ßÇ¥³âµµ 2020.01.07 ¹ßÇ¥Áö Curr Biol
Á¦ ¸ñ Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models
¹ßÇ¥³âµµ 2019.10.11 ¹ßÇ¥Áö Theranostics
Á¦ ¸ñ Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson's disease
¹ßÇ¥³âµµ 2019.09.30 ¹ßÇ¥Áö Parkinsonism Relat Disord

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¼­¿ï´ëº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1588-5700
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¼­¿ï´ëº´¿øÀº º»¿øÀ» ºñ·ÔÇÑ ¾î¸°À̺´¿ø, ¾Ïº´¿ø, ÀÇ»ý¸í¿¬±¸¿øÀ¸·Î ±¸¼ºµÅ ÀÖ´Â Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î 1786º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖ´Ù. 540¿© ¸íÀÇ ±³¼ö¿Í 5400¿© ¸íÀÇ Á÷¿øÀÌ ÇÏ·ç Æò±Õ 1700¿© ¸íÀÇ ÀÔ¿øÈ¯ÀÚ¿Í 8600¸íÀÌ ³Ñ´Â ¿Ü·¡È¯ÀÚ¸¦ µ¹º¸°í ÀÖ´Ù. ¼¼°èÀû ÷´Ü Áø·á ¿µ¿ªÀ» Áö¼ÓÀûÀ¸·Î È®º¸ÇÔÀ¸·Î½á ÃÖ»óÀÇ Áø·á ¼­ºñ½º¸¦ Á¦°øÇϰí, ¿ì¸®³ª¶ó ÀÇ·á ¼±ÁøÈ­¸¦ Ãß±¸ÇÏ´Â Á¤Ã¥ Çù·Â º´¿øÀÌ´Ù.

¼­¿ï´ëº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã Á¾·Î±¸ ´ëÇзΠ101

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä